Remed Co.Ltd (302550) - Total Liabilities

Latest as of December 2025: ₩14.45 Billion KRW ≈ $9.79 Million USD

Based on the latest financial reports, Remed Co.Ltd (302550) has total liabilities worth ₩14.45 Billion KRW (≈ $9.79 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Remed Co.Ltd (302550) cash conversion ratio to assess how effectively this company generates cash.

Remed Co.Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Remed Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Remed Co.Ltd (302550) asset resilience to evaluate the company's liquid asset resilience ratio.

Remed Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Remed Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Asia File Corporation Bhd KLSE:7129	Malaysia	RM53.88 Million
TAPEX INC KO:055490	Korea	₩39.20 Billion
Ardiden Ltd AU:ADV	Australia	AU$127.06K
MGB Bhd KLSE:7595	Malaysia	RM525.43 Million
Formosa Prosonic Industries KLSE:9172	Malaysia	RM102.68 Million
Quest For Growth - Pricaf BR:QFG	Belgium	€51.99K
Evergreen Corp NASDAQ:EVGR	USA	$11.69 Million
ad pepper media International N.V XETRA:APM	Germany	€36.46 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Remed Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Remed Co.Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Remed Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Remed Co.Ltd (2017–2025)

The table below shows the annual total liabilities of Remed Co.Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩14.45 Billion ≈ $9.79 Million	-23.22%
2024-12-31	₩18.81 Billion ≈ $12.75 Million	-22.47%
2023-12-31	₩24.27 Billion ≈ $16.44 Million	-49.66%
2022-12-31	₩48.21 Billion ≈ $32.67 Million	-5.66%
2021-12-31	₩51.10 Billion ≈ $34.63 Million	+4.97%
2020-12-31	₩48.68 Billion ≈ $32.99 Million	+371.60%
2019-12-31	₩10.32 Billion ≈ $7.00 Million	-2.32%
2018-12-31	₩10.57 Billion ≈ $7.16 Million	+25.67%
2017-12-31	₩8.41 Billion ≈ $5.70 Million	--

About Remed Co.Ltd

KQ:302550 Korea Medical Devices

Market Cap

$64.62 Million

₩95.35 Billion KRW

Market Cap Rank

#20885 Global

#1282 in Korea

Share Price

₩3085.00

Change (1 day)

-0.16%

52-Week Range

₩2755.00 - ₩3985.00

All Time High

₩4180.00